Engineered T Cells for the Adoptive Therapy of B-Cell Chronic Lymphocytic Leukaemia
Joint Authors
Schmidt, Patrick
Hallek, Michael
Hombach, Andreas A.
Abken, Hinrich
Koehler, Philipp
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-13, 13 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-08-08
Country of Publication
Egypt
No. of Pages
13
Main Subjects
Abstract EN
B-cell chronic lymphocytic leukaemia (B-CLL) remains an incurable disease due to the high risk of relapse, even after complete remission, raising the need to control and eliminate residual tumor cells in long term.
Adoptive T cell therapy with genetically engineered specificity is thought to fulfil expectations, and clinical trials for the treatment of CLL are initiated.
Cytolytic T cells from patients are redirected towards CLL cells by ex vivo engineering with a chimeric antigen receptor (CAR) which binds to CD19 on CLL cells through an antibody-derived domain and triggers T cell activation through CD3ζ upon tumor cell engagement.
Redirected T cells thereby target CLL cells in an MHC-unrestricted fashion, secret proinflammatory cytokines, and eliminate CD19+ leukaemia cells with high efficiency.
Cytolysis of autologous CLL cells by patient's engineered T cells is effective, however, accompanied by lasting elimination of healthy CD19+ B-cells.
In this paper we discuss the potential of the strategy in the treatment of CLL, the currently ongoing trials, and the future challenges in the adoptive therapy with CAR-engineered T cells.
American Psychological Association (APA)
Koehler, Philipp& Schmidt, Patrick& Hombach, Andreas A.& Hallek, Michael& Abken, Hinrich. 2011. Engineered T Cells for the Adoptive Therapy of B-Cell Chronic Lymphocytic Leukaemia. Advances in Hematology،Vol. 2012, no. 2012, pp.1-13.
https://search.emarefa.net/detail/BIM-483684
Modern Language Association (MLA)
Koehler, Philipp…[et al.]. Engineered T Cells for the Adoptive Therapy of B-Cell Chronic Lymphocytic Leukaemia. Advances in Hematology No. 2012 (2012), pp.1-13.
https://search.emarefa.net/detail/BIM-483684
American Medical Association (AMA)
Koehler, Philipp& Schmidt, Patrick& Hombach, Andreas A.& Hallek, Michael& Abken, Hinrich. Engineered T Cells for the Adoptive Therapy of B-Cell Chronic Lymphocytic Leukaemia. Advances in Hematology. 2011. Vol. 2012, no. 2012, pp.1-13.
https://search.emarefa.net/detail/BIM-483684
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-483684